ADx Health
ADx Health is a Bellingham, WA-based private genetic testing company operating a CLIA-certified laboratory, selling direct-to-consumer at-home and blood-based tests for Alzheimer's risk, pharmacogenomics, athletic performance, and gut health to consumers and referring healthcare providers.
- Company typePrivate
- Founded2016
- HeadquartersBellingham, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What ADx Health does
ADx Health (legal entity: Affirmativ Diagnostics PLLC) is a privately held genetic and diagnostic testing company founded in 2016 and headquartered in Bellingham, Washington. The company operates its own CLIA-certified and CAP-accredited clinical laboratory where all testing is performed in-house, and sells primarily direct-to-consumer through an e-commerce storefront (shop.adxhealth.com), supplemented by a network of referring physicians and wellness providers who access a dedicated Provider Portal.
The product portfolio is anchored on Alzheimer's disease diagnostics and has expanded into adjacent genetic and microbiome categories. Core products include GenoRisk™, an at-home saliva-based test that uses a proprietary polygenic risk score algorithm evaluating 31 genetic variants across 23 genes (including APOE) for late-onset Alzheimer's risk; WellMind, a blood-based p-Tau217 biomarker test capable of identifying amyloid-related pathology up to 18 years before clinical diagnosis; myGenoFit (athletic performance genetics), PGxComplete (pharmacogenomics), and BiomeIQ (gut microbiome). Each purchase includes a 15-minute telehealth consultation. Underlying technology relies on DNA extraction from saliva, PCR amplification, mass spectrometry-based variant detection, and statistical cross-validation of polygenic models, supported by a peer-reviewed publication authored by Scientific Director Dr. Ryan Fortna.
The business model is one-time direct payment for test kits via e-commerce, with pay-as-you-go pricing (specific prices not publicly disclosed), bundled telehealth, and a referral-driven B2B2C layer through partner providers. The company is privately held with no disclosed funding rounds or institutional investors, operates within a U.S.-only footprint with explicit exclusions for New York state and international orders, and maintains an active content marketing and scientific advisory presence to drive demand.
ADx Health firmographics
Firmographics- Name
- ADx Health
- Legal name
- Affirmativ Diagnostics PLLC
- Website
- https://adxhealth.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ADx Health is a Bellingham, WA-based private genetic testing company operating a CLIA-certified laboratory, selling direct-to-consumer at-home and blood-based tests for Alzheimer's risk, pharmacogenomics, athletic performance, and gut health to consumers and referring healthcare providers.
- Ownership category
- akta.pro rank
ADx Health industry classification
Industry- Product category
- Genetic Testing and Diagnostic Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Genetic & Prenatal Testing Laboratories (HLAFAMAH)
- akta.pro secondary industries
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where ADx Health is headquartered
LocationHeadquarters
- HQ city
- Bellingham
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
ADx Health business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Genetic Testing Kits: Direct-to-consumer sales of at-home genetic testing kits including GenoRisk Alzheimer's test, WellMind p-Tau217 blood test, myGenoFit athletic genetic test, and PGxComplete pharmacogenomics test. Customers purchase kits online and receive results through a secure portal with optional 15-minute telehealth consultation included.
- Telehealth Consultation Services: Optional add-on telehealth consultation with healthcare provider to review genetic testing results. Included in test purchase at no additional cost for initial 15-minute consultation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Genetic testing kits with included telehealth consultation |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
ADx Health product offering
Product offeringCore offering
ADx Health sells direct-to-consumer genetic testing and diagnostic kits, primarily focused on Alzheimer's disease risk assessment and early detection. Its flagship GenoRisk™ test uses a saliva sample to compute a polygenic risk score for late-onset Alzheimer's by evaluating 31 genetic variants across 23 genes, while its WellMind blood test measures the p-Tau217 biomarker to detect amyloid-pathology-related changes up to 18 years before clinical diagnosis. Additional offerings include the myGenoFit athletic genetics test, the PGxComplete pharmacogenomics test, and the BiomeIQ gut microbiome test, with each kit including a 15-minute telehealth consultation and results delivered via a secure online portal.
Product overview
ADx Health is a genetic testing company offering multiple at-home and blood-based diagnostic products focused on Alzheimer's disease, pharmacogenomics, athletic performance, and gut health. The core products include GenoRisk™ Alzheimer's (genetic risk assessment via saliva test), WellMind (blood-based p-Tau217 biomarker test for early Alzheimer's detection), myGenoFit (athletic genetic testing), PGxComplete (pharmacogenomics), and BiomeIQ (gut microbiome testing). All testing is performed in their CLIA-certified and CAP-accredited laboratory in Bellingham, WA.
Differentiator
Problem solved
Functional benefit
Brands
- GenoRisk™ Alzheimer’s: At-home genetic test providing a polygenic risk score for late-onset Alzheimer's disease using saliva sample
- WellMind
- BiomeIQ
- myGenoFit
- PGxComplete
Products and services
- GenoRisk™ Alzheimer's An at-home saliva-based genetic test that provides a polygenic risk score for late-onset Alzheimer's disease by evaluating 31 genetic variants across 23 different genes, including APOE status. Designed for adults who want to understand their genetic Alzheimer's risk, particularly those with a family history of dementia.
- WellMind A blood test for Alzheimer's disease that detects pathophysiological changes associated with amyloid pathology using the p-Tau217 biomarker, designed for early detection, and capable of identifying changes up to 18 years before clinical diagnosis. Customers book a blood draw appointment via the My One Medical Source phlebotomy partnership.
- myGenoFit A genetic test for athletes at any performance level that provides personalized reports on athletic ability, trainability, and injury risk, with actionable recommendations to enhance performance.
- PGxComplete An in-depth pharmacogenomics test that reviews how an individual's genetic makeup may affect their response to medications, supporting personalized medication choices.
- BiomeIQ A gut microbiome testing product that provides insights into gut bacteria composition to inform personalized dietary and supplement recommendations, particularly for conditions such as IBS.
Quantifiable outcome
- The GenoRisk test analyzes multiple genes rather than the APOE gene alone, with results having greater predictive accuracy than other tests
- +2 more outcomes
Companies that use ADx Health
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
ADx Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
ADx Health partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and support.
- My One Medical SourcecorePartnership for phlebotomy services to support the WellMind blood test. My One Medical Source provides draw site locations where customers can have their blood drawn for shipping to ADx Health's Bellingham, WA laboratory. Customers book appointments through My One Medical Source's platform.
- Translational Research Associates (TRAs)supportTRA's provide support to providers and patients through the Provider Portal, answering questions and providing referrals to genetic counselors as needed.
- Scientific Advisory Board MemberscoreExpert advisors including Robin Everts PhD (Etalon Diagnostics), Ryan Fortna MD PhD (Avero Diagnostics), Eric Hegedus PhD (Tufts University), William Kraus MD (Duke University), and Jennifer Stagg ND (Whole Health Wellness Center) providing guidance on product development and scientific research.
Scale indicators4 records
Recent moves4 records
Expansion highlights5 records
ADx Health competitors and assessment
Company assessmentDirect peers
- C2N Diagnostics: C2N Diagnostics offers the PrecivityAD blood test for Alzheimer's pathology (Aβ42/40 ratio) via clinician order, directly comparable to ADx Health's WellMind p-Tau217 blood-based early detection test for the same patient and provider audience.
- 23andMe: 23andMe is a leading direct-to-consumer genetic testing company covering health risk (including Alzheimer's via APOE), ancestry, and pharmacogenomics — overlapping ADx Health's DTC channel, kit logistics, and consumer genomics positioning.
- Color Health: Color Health delivers clinical-grade genetic testing for cancer, cardiovascular, and pharmacogenomics with both consumer and provider channels, overlapping ADx Health's PGxComplete offering and provider-portal-driven GTM.
- Helix: Helix operates a clinical-grade DNA testing platform serving both consumers and health systems with a menu of genetic tests, comparable to ADx Health's mix of DTC kits (GenoRisk, myGenoFit) plus provider-driven testing.
- Ancestry: AncestryDNA is one of the largest DTC genetic testing brands, sharing ADx Health's e-commerce kit model, saliva-sample logistics, and consumer genomics marketing playbook.
Broad incumbents
- Myriad Genetics: Myriad Genetics is an established clinical diagnostics company offering genetic risk tests (including psychiatric and neurological risk panels) with a broader hospital and specialist channel — overlapping ADx Health's genetic testing menu at a much larger scale.
- Quest Diagnostics: Quest Diagnostics is a national clinical laboratory offering genetic, pharmacogenomic, and Alzheimer's-related biomarker tests ordered through physicians — overlapping ADx Health's clinical lab service and provider-referred testing from a much larger infrastructure base.
- Laboratory Corporation of America (Labcorp): Labcorp is a major clinical reference laboratory providing genetic and specialty testing including pharmacogenomics and neurological biomarkers, comparable to ADx Health's CLIA-certified lab services for both consumers and providers.
Emerging players
- Sema4: Sema4 (and its GeneDx oncology/reproductive health spin) operates a clinical genomic testing platform with health system and provider channels, partially overlapping ADx Health's provider-portal genetic testing approach at a smaller scale.
- Genetic Technologies (Phenogen Sciences): Genetic Technologies offers consumer and clinical polygenic risk score tests (including for breast cancer and metabolic disease), a comparable niche player in PRS-based risk assessment where ADx Health is also positioned with its GenoRisk Alzheimer's PRS.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
ADx Health social profiles
Digital presenceADx Health compliance and trust
Trust signalCompliance3 records
ADx Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
ADx Health leadership team
Management profileNumber of profiles
Profiles5 records
ADx Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ADx Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ADx Health
What does ADx Health do?
ADx Health sells direct-to-consumer genetic testing and diagnostic kits, primarily focused on Alzheimer's disease risk assessment and early detection. Its flagship GenoRisk™ test uses a saliva sample to compute a polygenic risk score for late-onset Alzheimer's by evaluating 31 genetic variants across 23 genes, while its WellMind blood test measures the p-Tau217 biomarker to detect amyloid-pathology-related changes up to 18 years before clinical diagnosis. Additional offerings include the myGenoFit athletic genetics test, the PGxComplete pharmacogenomics test, and the BiomeIQ gut microbiome test, with each kit including a 15-minute telehealth consultation and results delivered via a secure online portal.
Is ADx Health a public or private company?
ADx Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ADx Health founded?
ADx Health was founded in 2016. It employs 1 to 10 people.
Where is ADx Health based?
ADx Health is headquartered in Bellingham, United States, in the North America region.
How does ADx Health make money?
Two revenue lines are on record. Genetic Testing Kits are the primary driver. The others are telehealth Consultation Services.
Who are ADx Health's main competitors?
Direct peers on record are C2N Diagnostics, 23andMe, Color Health, Helix and Ancestry. Broad incumbents are Myriad Genetics, Quest Diagnostics and Laboratory Corporation of America (Labcorp). Emerging players are Sema4 and Genetic Technologies (Phenogen Sciences).
Does ADx Health have an API?
No public API is recorded for ADx Health.
What industry is ADx Health in?
ADx Health's product category is Genetic Testing and Diagnostic Services. Its primary akta.pro industry code is HLAFAMAH, Genetic & Prenatal Testing Laboratories, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.